$CYDY
CytoDyn Inc.

2013 Q2 Form 10-Q Financial Statement

#000119312513153010 Filed on April 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.330M $1.590M $1.340M
YoY Change -59.33% 18.66% 59.52%
% of Gross Profit
Research & Development $370.0K $33.37K $71.50K
YoY Change 208.33% -53.33% -68.91%
% of Gross Profit
Depreciation & Amortization $220.0K $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.910M $1.623M $1.415M
YoY Change -43.66% 14.69% 32.24%
Operating Profit -$1.623M -$1.415M
YoY Change 14.69%
Interest Expense -$940.0K -$1.060M $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $370.0K $320.0K
YoY Change
Pretax Income -$2.490M -$2.359M -$1.418M
YoY Change -26.55% 66.39% 31.28%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.490M -$2.359M -$1.418M
YoY Change -26.55% 66.39% 31.28%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$80.95K -$78.07K -$55.71K
COMMON SHARES
Basic Shares Outstanding 30.89M shares 30.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $600.0K $410.0K $1.780M
YoY Change 114.29% -76.97% 270.83%
Cash & Equivalents $603.7K $412.0K $1.780M
Short-Term Investments
Other Short-Term Assets $240.0K $530.0K $730.0K
YoY Change -68.0% -27.4% -74.65%
Inventory
Prepaid Expenses $139.8K $105.3K
Receivables
Other Receivables
Total Short-Term Assets $840.5K $940.8K $2.510M
YoY Change -18.27% -62.52% -25.07%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Goodwill
YoY Change
Intangibles $3.317M
YoY Change 8491.66%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.317M $3.539M $50.00K
YoY Change 7698.85% 6977.66% 66.67%
TOTAL ASSETS
Total Short-Term Assets $840.5K $940.8K $2.510M
Total Long-Term Assets $3.317M $3.539M $50.00K
Total Assets $4.158M $4.480M $2.560M
YoY Change 288.27% 74.99% -24.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.111M $899.9K $760.0K
YoY Change 33.67% 18.4% 52.0%
Accrued Expenses $321.9K $148.9K $40.00K
YoY Change 113.77% 272.25% -97.71%
Deferred Revenue
YoY Change
Short-Term Debt $330.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $328.3K
YoY Change
Total Short-Term Liabilities $3.229M $3.930M $5.000M
YoY Change -35.99% -21.39% -36.22%
LONG-TERM LIABILITIES
Long-Term Debt $1.153M $680.0K $10.00K
YoY Change 6700.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.153M $680.0K $10.00K
YoY Change 6700.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.229M $3.930M $5.000M
Total Long-Term Liabilities $1.153M $680.0K $10.00K
Total Liabilities $4.382M $4.607M $5.010M
YoY Change -13.14% -8.05% -36.1%
SHAREHOLDERS EQUITY
Retained Earnings -$34.00M
YoY Change
Common Stock $16.14M $16.42M
YoY Change 6.56%
Preferred Stock
YoY Change
Treasury Stock (at cost) $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares 200.0K shares 200.0K shares
Shareholders Equity -$223.9K -$127.3K -$2.460M
YoY Change
Total Liabilities & Shareholders Equity $4.158M $4.480M $2.560M
YoY Change 288.27% 74.99% -24.26%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$2.490M -$2.359M -$1.418M
YoY Change -26.55% 66.39% 31.28%
Depreciation, Depletion And Amortization $220.0K $0.00 $0.00
YoY Change
Cash From Operating Activities -$990.0K -$1.230M -$1.580M
YoY Change -34.44% -22.15% 187.27%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.180M 220.0K 3.240M
YoY Change 11700.0% -93.21% 248.39%
NET CHANGE
Cash From Operating Activities -990.0K -1.230M -1.580M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 1.180M 220.0K 3.240M
Net Change In Cash 190.0K -1.010M 1.660M
YoY Change -112.67% -160.84% 336.84%
FREE CASH FLOW
Cash From Operating Activities -$990.0K -$1.230M -$1.580M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$990.0K -$1.230M -$1.580M
YoY Change -34.44% -22.15% 187.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30893149 shares
CY2003Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3238
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1779913
CY2013Q1 us-gaap Liabilities Subject To Compromise Early Contract Termination Fees
LiabilitiesSubjectToCompromiseEarlyContractTerminationFees
413000
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
671571
CY2013Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
31517277
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16833232 shares
CY2013Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
-127302
CY2013Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
38828
CY2013Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5908250
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1793958
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.75
CY2013Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5908250
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
200000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.67
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1793958
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30745671 shares
CY2013Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q1 us-gaap Liabilities
Liabilities
4606928
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
899869
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
105263
CY2013Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
29915365
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2013Q1 us-gaap Assets
Assets
4479626
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.68
CY2013Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
667571
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4479626
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
100000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
412049
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30945671 shares
CY2013Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
9000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
148900
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3930357
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18038297 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
16423954
CY2013Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
423486
CY2013Q1 us-gaap Interest Payable Current
InterestPayableCurrent
124104
CY2013Q1 us-gaap Assets Current
AssetsCurrent
940798
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
95100 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
95100 shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
363497
CY2013Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
413484
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16754072
CY2013Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
5.00
CY2013Q1 cydy Potential Royalty Payment As Percentage Of Net Sales
PotentialRoyaltyPaymentAsPercentageOfNetSales
0.115 pure
CY2013Q1 cydy Intangible Assets Net Non Current
IntangibleAssetsNetNonCurrent
3500000
CY2013Q1 cydy Working Capital Deficit
WorkingCapitalDeficit
2989559
CY2013Q1 cydy Accumulated Deficit On Unrelated Dormant Operations
AccumulatedDeficitOnUnrelatedDormantOperations
-1601912
CY2013Q1 cydy Additional Paid In Capital Treasury Stock
AdditionalPaidInCapitalTreasuryStock
279952
CY2013Q1 cydy Common And Preferred Stock Subject To Rescission
CommonAndPreferredStockSubjectToRescission
-2344000
CY2013Q1 cydy Common Stock Payable
CommonStockPayable
12500
CY2013Q1 cydy Stock Rescission Liability
StockRescissionLiability
2344000
CY2013Q1 cydy Minimum Annual License Fee For Purchase Obligations
MinimumAnnualLicenseFeeForPurchaseObligations
150000
CY2013Q1 cydy Rescission Liability
RescissionLiability
2344000
CY2010Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
5.00
CY2010Q2 us-gaap Preferred Stock Value
PreferredStockValue
2009000
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1037818
CY2012Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
-3973434
CY2012Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
41735
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
200000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2308279
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28636530 shares
CY2012Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2012Q2 us-gaap Liabilities
Liabilities
5044269
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
831336
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
65982
CY2012Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
22832606
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2012Q2 us-gaap Assets
Assets
1070835
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.60
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1070835
CY2012Q2 us-gaap Treasury Stock Value
TreasuryStockValue
100000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
284991
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28836530 shares
CY2012Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
74493
CY2012Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
9000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
150573
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5035269
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10327664 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
15150261
CY2012Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
677327
CY2012Q2 us-gaap Interest Payable Current
InterestPayableCurrent
40618
CY2012Q2 us-gaap Assets Current
AssetsCurrent
1028300
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
98900 shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
98900 shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
451993
CY2012Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
189249
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
800
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8020533
CY2012Q2 cydy Accumulated Deficit On Unrelated Dormant Operations
AccumulatedDeficitOnUnrelatedDormantOperations
-1601912
CY2012Q2 cydy Additional Paid In Capital Treasury Stock
AdditionalPaidInCapitalTreasuryStock
299297
CY2012Q2 cydy Common And Preferred Stock Subject To Rescission
CommonAndPreferredStockSubjectToRescission
-3749000
CY2012Q2 cydy Common Stock Payable
CommonStockPayable
388000
CY2012Q2 cydy Stock Rescission Liability
StockRescissionLiability
3749000
CY2012Q2 cydy Rescission Liability
RescissionLiability
3749000
dei Trading Symbol
TradingSymbol
CYDY
dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-02-28
dei Entity Central Index Key
EntityCentralIndexKey
0001175680
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2396065
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>Reclassifications</b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the fiscal 2012 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total shareholders&#x2019; equity (deficit), or net loss.</font></p> </div>
us-gaap Operating Income Loss
OperatingIncomeLoss
-6078540
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y7D
us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2016-01-15
us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-2190
us-gaap Share Based Compensation
ShareBasedCompensation
3025777
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.70
us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
0.25
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
831545
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.00
us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2015-10-01
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
755000 shares
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
567000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3934
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3503135
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2907
us-gaap Investment Income Interest
InvestmentIncomeInterest
1015
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1234571
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3135
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
127058
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5120807
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9615633 shares
us-gaap Legal Fees
LegalFees
698974
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7082759
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
254825
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6026258
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
39281
us-gaap Interest Expense Debt
InterestExpenseDebt
143422
us-gaap Operating Expenses
OperatingExpenses
6078540
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1150000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M21D
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1128000
us-gaap Interest Paid
InterestPaid
55731
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29670735 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1234571
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18038297 shares
us-gaap Net Income Loss
NetIncomeLoss
-7082759
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5908250
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7084949
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">The preparation of the condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (&#x201C;U.S. GAAP&#x201D;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
cydy Number Of Sublicenses Acquired
NumberOfSublicensesAcquired
2 Patent
cydy Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
372759
cydy Payment Of Indebtedness
PaymentOfIndebtedness
74492
cydy Gain On Settlements Of Accounts Payable
GainOnSettlementsOfAccountsPayable
372759
cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
cydy Affirmative Defenses
AffirmativeDefenses
0 Claim
cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
253841
cydy Common Stock Issued For Accrued Interest Payable
CommonStockIssuedForAccruedInterestPayable
4205
cydy Common Stock Issued For Conversion Of Convertible Debt
CommonStockIssuedForConversionOfConvertibleDebt
567000
cydy Common Stock Issued For Series B Preferred Stock
CommonStockIssuedForSeriesBPreferredStock
19000
cydy Common Stock Issued On Payment Of Accounts Payable
CommonStockIssuedOnPaymentOfAccountsPayable
80000
cydy Constructive Dividend To Preferred Stock Holders
ConstructiveDividendToPreferredStockHolders
6000000
cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00 pure
cydy Number Of Patent License Agreement
NumberOfPatentLicenseAgreement
3 Patent
cydy Number Of Unbarred Claims In Foreign
NumberOfUnbarredClaimsInForeign
5 Claim
cydy Number Of Unbarred Claims In State
NumberOfUnbarredClaimsInState
17 Claim
cydy Original Issue Discount And Intrinsic Value Of Beneficial Conversion Feature Related To Debt
OriginalIssueDiscountAndIntrinsicValueOfBeneficialConversionFeatureRelatedToDebt
5908250
cydy Possible Claims By Investors
PossibleClaimsByInvestors
6400000
cydy Possible Claims By Potential State Or Foreign Jurisdiction
PossibleClaimsByPotentialStateOrForeignJurisdiction
2300000
cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
1405000
cydy Series B Preferred Stock Dividends
SeriesBPreferredStockDividends
2190
cydy Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
192500
us-gaap Operating Income Loss
OperatingIncomeLoss
-4065345
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3386024
us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-67293
us-gaap Share Based Compensation
ShareBasedCompensation
1362665
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-166498
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1621
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2884837
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
742095
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2725617
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
28153
us-gaap Legal Fees
LegalFees
923968
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4082037
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
414139
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3626932
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-22649
us-gaap Interest Expense Debt
InterestExpenseDebt
16692
us-gaap Operating Expenses
OperatingExpenses
4065345
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.18
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2853
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1500
us-gaap Interest Paid
InterestPaid
4026
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23331326 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2063
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8331576 shares
us-gaap Net Income Loss
NetIncomeLoss
-4082037
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4149330
cydy Payment Of Indebtedness
PaymentOfIndebtedness
74492
cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
182198
cydy Common Stock Issued For Series B Preferred Stock
CommonStockIssuedForSeriesBPreferredStock
835000
cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
717000
cydy Series B Preferred Stock Dividends
SeriesBPreferredStockDividends
67293
cydy Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
316900
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2012Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
66116 shares
CY2012Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
80000
CY2012Q4 cydy Cash Payment For Services
CashPaymentForServices
45000
CY2012Q4 cydy Trade Payable Settlement
TradePayableSettlement
447000
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
CY2007Q3 us-gaap Notes Issued1
NotesIssued1
150000
CY2007Q3 cydy Notes Issued Interest Percentage
NotesIssuedInterestPercentage
0.14 pure
CY2012Q4 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
3500000
us-gaap Operating Income Loss
OperatingIncomeLoss
-28373420
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8966072
us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-99483
us-gaap Share Based Compensation
ShareBasedCompensation
11603175
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2342777
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
436000
us-gaap Stock Issued1
StockIssued1
63600
us-gaap Depreciation And Amortization
DepreciationAndAmortization
186796
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14405428
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3524218
us-gaap Investment Income Interest
InvestmentIncomeInterest
2642
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1234571
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24218
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
408811
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21582699
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
34500
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
38828
us-gaap Legal Fees
LegalFees
3589605
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
6000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-29915365
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3014320
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18338457
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
105263
us-gaap Interest Expense Debt
InterestExpenseDebt
1020117
us-gaap Proceeds From Sale Of Interest In Corporate Unit
ProceedsFromSaleOfInterestInCorporateUnit
512200
us-gaap Operating Expenses
OperatingExpenses
28373420
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-2.33
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3146
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1500
us-gaap Interest Paid
InterestPaid
28055
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15441958 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1953836
us-gaap Net Income Loss
NetIncomeLoss
-29915365
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
145000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6594250
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36014848
us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
559210
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2009000
cydy Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
710101
cydy Payment Of Indebtedness
PaymentOfIndebtedness
314482
cydy Gain On Settlements Of Accounts Payable
GainOnSettlementsOfAccountsPayable
710101
cydy Accrued Salaries Related Party Contributed As Capital
AccruedSalariesRelatedPartyContributedAsCapital
229500
cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
452938
cydy Capital Contributions By President
CapitalContributionsByPresident
15748
cydy Common Stock Issued For Accrued Interest Payable
CommonStockIssuedForAccruedInterestPayable
25161
cydy Common Stock Issued For Conversion Of Convertible Debt
CommonStockIssuedForConversionOfConvertibleDebt
1229000
cydy Common Stock Issued For Debt
CommonStockIssuedForDebt
245582
cydy Common Stock Issued For Preferred Stock
CommonStockIssuedForPreferredStock
167500
cydy Common Stock Issued For Series B Preferred Stock
CommonStockIssuedForSeriesBPreferredStock
1526484
cydy Common Stock Issued On Payment Of Accounts Payable
CommonStockIssuedOnPaymentOfAccountsPayable
129000
cydy Common Stock Issued To Former Officer To Repay Working Capital Advance
CommonStockIssuedToFormerOfficerToRepayWorkingCapitalAdvance
5000
cydy Constructive Dividend
ConstructiveDividend
6000000
cydy Net Assets Acquired In Exchange For Common Stock In Business Combination
NetAssetsAcquiredInExchangeForCommonStockInBusinessCombination
7542
cydy Options To Purchase Common Stock Issued For Debt
OptionsToPurchaseCommonStockIssuedForDebt
62341
cydy Original Issue Discount And Intrinsic Value Of Beneficial Conversion Feature Related To Debt
OriginalIssueDiscountAndIntrinsicValueOfBeneficialConversionFeatureRelatedToDebt
6516516
cydy Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
1029940
cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
2344000
cydy Proceeds From Issuance Of Stock Of Business Units Acquisition
ProceedsFromIssuanceOfStockOfBusinessUnitsAcquisition
100000
cydy Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
705649
cydy Purchased In Process Research And Development
PurchasedInProcessResearchAndDevelopment
274399
cydy Series B Preferred Stock Dividends
SeriesBPreferredStockDividends
99483
cydy Treasury Stock Issued For Prepaid Services
TreasuryStockIssuedForPrepaidServices
118291
cydy Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
547750
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1622738
CY2013Q1 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-790
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3109
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
697
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
977258
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1352515
CY2013Q1 us-gaap Legal Fees
LegalFees
233744
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2359107
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33370
CY2013Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
82141
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
1622738
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.08
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30229176 shares
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-2359107
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2359897
CY2013Q1 cydy License Fee Payments
LicenseFeePayments
150000
CY2013Q1 cydy Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
322333
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1414925
CY2012Q1 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-67293
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
391
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1073431
CY2012Q1 us-gaap Legal Fees
LegalFees
269603
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1417847
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71500
CY2012Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2922
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
1414925
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.06
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25448777 shares
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-1417847
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1485140

Files In Submission

Name View Source Status
0001193125-13-153010-index-headers.html Edgar Link pending
0001193125-13-153010-index.html Edgar Link pending
0001193125-13-153010.txt Edgar Link pending
0001193125-13-153010-xbrl.zip Edgar Link pending
cydy-20130228.xml Edgar Link completed
cydy-20130228.xsd Edgar Link pending
cydy-20130228_cal.xml Edgar Link unprocessable
cydy-20130228_def.xml Edgar Link unprocessable
cydy-20130228_lab.xml Edgar Link unprocessable
cydy-20130228_pre.xml Edgar Link unprocessable
d513428d10q.htm Edgar Link pending
d513428dex101.htm Edgar Link pending
d513428dex311.htm Edgar Link pending
d513428dex312.htm Edgar Link pending
d513428dex321.htm Edgar Link pending
d513428dex322.htm Edgar Link pending
d513428dex41.htm Edgar Link pending
d513428dex42.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending